BIOMAT Database Logo BIOMAT Database Logo

[Effects of aprotinin on activated coagulation time in the patients during cardiopulmonary bypass]. 1998

L Xu, and Z He, and J Shen

UI MeSH Term Description Entries
D007611 Aprotinin A single-chain polypeptide derived from bovine tissues consisting of 58 amino-acid residues. It is an inhibitor of proteolytic enzymes including CHYMOTRYPSIN; KALLIKREIN; PLASMIN; and TRYPSIN. It is used in the treatment of HEMORRHAGE associated with raised plasma concentrations of plasmin. It is also used to reduce blood loss and transfusion requirements in patients at high risk of major blood loss during and following open heart surgery with EXTRACORPOREAL CIRCULATION. (Reynolds JEF(Ed): Martindale: The Extra Pharmacopoeia (electronic version). Micromedex, Inc, Englewood, CO, 1995) BPTI, Basic Pancreatic Trypsin Inhibitor,Basic Pancreatic Trypsin Inhibitor,Bovine Kunitz Pancreatic Trypsin Inhibitor,Kallikrein-Trypsin Inactivator,Kunitz Pancreatic Trypsin Inhibitor,Trypsin Inhibitor, Basic, Pancreatic,Trypsin Inhibitor, Kunitz, Pancreatic,Antilysin,Bovine Pancreatic Trypsin Inhibitor,Contrical,Contrykal,Dilmintal,Iniprol,Kontrikal,Kontrykal,Pulmin,Traskolan,Trasylol,Zymofren,Inactivator, Kallikrein-Trypsin,Kallikrein Trypsin Inactivator
D008297 Male Males
D002315 Cardiopulmonary Bypass Diversion of the flow of blood from the entrance of the right atrium directly to the aorta (or femoral artery) via an oxygenator thus bypassing both the heart and lungs. Heart-Lung Bypass,Bypass, Cardiopulmonary,Bypass, Heart-Lung,Bypasses, Cardiopulmonary,Bypasses, Heart-Lung,Cardiopulmonary Bypasses,Heart Lung Bypass,Heart-Lung Bypasses
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D002675 Child, Preschool A child between the ages of 2 and 5. Children, Preschool,Preschool Child,Preschool Children
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D014914 Whole Blood Coagulation Time The time required by whole blood to produce a visible clot. Activated Coagulation Time, Whole Blood,Blood Coagulation Time, Whole,Coagulation Time, Whole Blood

Related Publications

L Xu, and Z He, and J Shen
[Heparin management by activated coagulation time during cardiopulmonary bypass].
January 1981, Kyobu geka. The Japanese journal of thoracic surgery,
L Xu, and Z He, and J Shen
Effects of aprotinin on hemostatic mechanisms during cardiopulmonary bypass.
December 1987, The Annals of thoracic surgery,
L Xu, and Z He, and J Shen
Effects of aprotinin during cardiopulmonary bypass in patients treated with acetylsalicylic acid.
January 1998, Scandinavian cardiovascular journal : SCJ,
L Xu, and Z He, and J Shen
The effect of temperature and aprotinin during cardiopulmonary bypass on three different methods of activated clotting time measurement.
September 2005, The journal of extra-corporeal technology,
L Xu, and Z He, and J Shen
Effects of different forms of aprotinin during cardiopulmonary bypass.
January 1993, Acta anaesthesiologica Belgica,
L Xu, and Z He, and J Shen
Low activated coagulation time during cardiopulmonary bypass does not increase postoperative bleeding.
March 1990, The Annals of thoracic surgery,
L Xu, and Z He, and J Shen
Guidelines for monitoring heparin by the activated clotting time when aprotinin is used during cardiopulmonary bypass.
July 1992, The Journal of thoracic and cardiovascular surgery,
L Xu, and Z He, and J Shen
Activated coagulation time method for control of heparin is reliable during cardiopulmonary bypass.
February 1984, Anesthesiology,
L Xu, and Z He, and J Shen
Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
May 1993, The Annals of thoracic surgery,
L Xu, and Z He, and J Shen
Kaolin-based activated coagulation time measured by sonoclot in patients undergoing cardiopulmonary bypass.
August 2007, Journal of cardiothoracic and vascular anesthesia,
Copied contents to your clipboard!